Not so selective serotonin reuptake inhibitors

Journal of Clinical Psychiatry

Volumn 59, Issue 7, 1998, Pages 343-344

  Stahl, Stephen M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG TOLERABILITY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0031829711     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.v59n0701     Document Type: Short Survey

References (7)

1. Feighner JP, Boyer WF. Selective Serotonin Reuptake Inhibitors. Chichester, England: John Wiley & Sons; 1996
2. Stahl SM. Essential Psychopharmacology. New York, NY: Cambridge University Press; 1996
3. Milne RJ, Goa KL. Citalopram: a review of its pharmacokinetic potential in depressive illness. Drugs 1991;41:450-479
4. Bolden-Watson C, Richelson E. Blockade by newly developed antidepressants of biologic amine uptake into rat brain synaptosomes. Life Sci 1993;52:1023-1029
5. Hyttel J. Comparative pharmacology of selective serotonin reuptake inhibitors. Nord J Psychiatry 1993;47(suppl 30):5-20
6. Norita N, Hashimoto K, Tomitaka S, et al. Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brains. Eur J Pharmacol 1996;307:117-119
7. Palvimake EP, Roth BL, Majasuo H, et al. Interactions of selective serotonin reuptake inhibitors with the serotonin 2C receptor. Psychopharmacology (Berl) 1996;126:234-240